GeneNews Ltd. | Income Statement
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
132.10
2,453.50
416.80
1,396.60
534.40
240.90
Cost of Goods Sold (COGS) incl. D&A
293.50
-
-
2,006.80
1,867.70
1,671.50
Gross Income
161.40
-
-
610.20
1,333.40
1,430.50
SG&A Expense
5,353.20
4,833.00
4,134.00
5,005.80
5,190.80
4,037.60
EBIT
5,514.50
-
3,722.60
5,615.90
6,524.20
5,468.10
Unusual Expense
1,294.40
-
113.40
493.50
3,423.40
2,013.10
Non Operating Income/Expense
36.90
31.80
75.70
34.30
170.60
192.70
Interest Expense
1,874.80
6.00
57.10
1,118.00
554.30
1,464.20
Pretax Income
8,672.00
2,427.70
3,817.40
7,261.70
3,825.70
5,111.90
Income Tax
-
-
92.10
-
-
-
Equity in Affiliates
734.40
5,249.00
3,972.40
569.90
-
-
Consolidated Net Income
9,406.40
7,676.70
7,697.70
7,831.70
3,825.70
5,111.90
Net Income
9,406.40
7,676.70
7,697.70
7,831.70
3,825.70
5,111.90
Net Income After Extraordinaries
9,406.40
7,676.70
7,697.70
7,831.70
3,825.70
5,111.90
Net Income Available to Common
9,406.40
7,676.70
7,697.70
7,831.70
3,825.70
5,111.90
EPS (Basic)
0.28
0.14
0.14
0.12
0.04
0.04
Basic Shares Outstanding
34,105.80
47,371.40
53,415.60
65,794.30
96,640.80
136,867.70
EPS (Diluted)
0.28
0.16
0.14
0.12
0.04
0.04
Diluted Shares Outstanding
34,105.80
47,371.40
53,415.60
65,794.30
96,640.80
136,867.70
EBITDA
5,221.00
2,379.50
3,717.20
5,163.10
6,073.30
5,065.30
Non-Operating Interest Income
48.60
8.90
-
-
-
-
About GeneNews
View Profile
